BIRC5 and esophageal squamous cell carcinoma: To further investigate the effect of survivin on DSE against esophageal squamous cell carcinoma, survivin inhibitor YM155 was firstly used to treat the ESCC cells and then the effects of DSE on proliferation, apoptosis, migration, invasion and tube formation ability were detected.